Clinical Study of PuraMed BioScience Product LipiGesic(TM) M Accepted for Publication in Top-Ranked Medical Journal

SCHOFIELD, Wis., April 6, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCQB:PMBS) announced today that the independent clinical study of LipiGesic™ M has been accepted for publication in a top-ranked medical journal.
MORE ON THIS TOPIC